I hate to see Biota is still related to GSK. Now GSK is in strategic alliance with Daiichi Sankyo, I am afraid "tricks" could again be played to undermine Biota's interest in Lani. As it is more and more clear that Biota's products, Relenza, Lani, and Vapendavir, will seriously undermine GSK's sales in some of its products, i.e. Flu vaccines, Panodal, and Asthmatic drugs.
Just my thoughts.
- Forums
- ASX - By Stock
- BTA
- tamiflu sales
tamiflu sales, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)